November 2025

Salarius Pharmaceuticals

Salarius Pharmaceuticals

Financial Advisor to Salarius Pharmaceuticals on its Merger with Decoy Therapeutics

Canaccord Genuity Advises Salarius Pharmaceuticals on its Merger with Decoy Therapeutics

More Like This

C$179m

March 2026

Canopy Growth

Exclusive Financial Advisor to Canopy Growth on its Acquisition of MTL Cannabis
US$230m

February 2026

Palvella Therapeutics

Joint Bookrunner (Public Offering)
US$265m

February 2026

Tandem Diabetes Care

Co-Manager (Conv. Notes Offering)

View all Healthcare transactions